Many Oncologists Discuss, Recommend Medical Marijuana

Share this content:
But majority of oncologists don't feel knowledgeable enough to make these recommendations
But majority of oncologists don't feel knowledgeable enough to make these recommendations

HealthDay News — Many oncologists recommend medical marijuana (MM) clinically despite not feeling sufficiently knowledgeable about its utility, according to a study published online May 10 in the Journal of Clinical Oncology.

Ilana M. Braun, MD, from the Dana-Farber Cancer Institute in Boston, and colleagues surveyed 400 medical oncologists regarding their beliefs, knowledge, and practices regarding MM (response rate, 63%).

The researchers found that only 30% of oncologists felt sufficiently informed to make recommendations regarding MM. Far more (80%) discussed MM with patients, while 46% clinically recommended MM. Roughly two-thirds of respondents viewed MM as a helpful adjunct to standard pain management strategies; a similar proportion viewed MM as equally or more effective than standard treatments for anorexia/cachexia.

"These findings are clinically important and suggest critical gaps in research, medical education, and policy regarding MM," the authors write.

Abstract/Full Text (subscription or payment may be required)

You must be a registered member of Clinical Advisor to post a comment.

Sign Up for Free e-newsletters